beta-Adrenergic-receptor and adenylate cyclase properties in pregnant and nonpregnant guinea pig myometrium.
Stimulation of myometrial beta-adrenergic receptors by agonists results in myometrial relaxation through adenylate cyclase-dependent mechanisms. Their activity is modulated by local or systemic estrogen-progesterone milieu. During pregnancy, guinea pigs demonstrate an ovarioplacental shift for progesterone production at less than or equal to 0.35 gestation and a gradual increase in estrogen levels. To investigate whether these changes affect myometrial beta-adrenergic-receptor and adenylate cyclase properties, we directly characterized beta-adrenergic receptors and adenylate cyclase in myometrial plasma membranes from time-dated pregnant (term 65 days), postpartum, and nonpregnant virgin guinea pigs by well-established in vitro methods. In all animals, there appeared to be a high-affinity, low-capacity, single class of binding sites with pharmacologic specificities consistent with the beta 2-adrenergic-receptor subtype. The dissociation constants of these beta-adrenergic receptors were significantly decreased in pregnant animals at approximately greater than or equal to 0.80 gestation when compared to pregnant animals at 0.35 to 0.40 gestation, nonpregnant animals, and postpartum animals. Moreover, the total number of beta-adrenergic receptors was significantly higher at greater than or equal to 0.80 gestation than in the other groups. Basal adenylate cyclase activity increased in animals from 0.35 to greater than or equal to 0.8 gestation and was higher than that of postpartum animals and nonpregnant animals. The degree of adenylate cyclase stimulation by (-)isoproterenol was higher at term than at an earlier point in gestation or in nonpregnant and postpartum animals. These results indicate that, with advancing gestation in pregnant animals, there is an up-regulation of beta-adrenergic-receptor and adenylate cyclase function.
Hatjis
C G
CG
D000262:Adenylyl Cyclases / Q000378:metabolism*; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000818:Animals; D001665:Binding Sites; D001667:Binding, Competitive; D005260:Female; D006168:Guinea Pigs; D066298:In Vitro Techniques; D009215:Myometrium / Q000201:enzymology / Q000378:metabolism*; D010869:Pindolol / Q000031:analogs & derivatives / Q000378:metabolism; D049590:Postpartum Period; D011247:Pregnancy; D011270:Pregnancy, Animal; D011943:Receptors, Adrenergic, beta / Q000378:metabolism*; D013997:Time Factors
D000318:Adrenergic beta-Agonists; D011943:Receptors, Adrenergic, beta; C012357:hydroxybenzylpindolol; D010869:Pindolol; D000262:Adenylyl Cyclases